AmMax Bio, Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis (NCT05349760) | AmMax Bio, Inc. | 2023-03-01 |
| A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT (NCT05349643) | AmMax Bio, Inc. | 2023-01-26 |
| A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients (NCT04938180) | AmMax Bio, Inc. | 2021-09-16 |
| An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee (NCT04731675) | AmMax Bio, Inc. | 2021-05-25 |
Track AmMax Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.